Zurich Cantonal Bank’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
Other funds holding HRMY
AC
Zurich Cantonal Bank's HRMY Position: Q2 2026 in Review
Zurich Cantonal Bank reduced its Harmony Biosciences (HRMY) stake by 15% in Q2 2026, selling an estimated $64.9K and leaving 11,313 shares worth $412K. The position accounts for ﹤0.01% of the portfolio, ranked #2045.
Zurich Cantonal Bank first reported a position in HRMY in Q4 2021 and has held it in 19 quarters since. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.
- Zurich Cantonal Bank held 11,313 shares of Harmony Biosciences worth $412K as of Q2 2026.
- Zurich Cantonal Bank sold 2,056 Harmony Biosciences shares in Q2 2026, an estimated $64.9K.
- Harmony Biosciences made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #2045 holding.
- Zurich Cantonal Bank first reported a position in Harmony Biosciences in Q4 2021 and has held it in 19 quarters since.
- 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.
Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.